Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01899326
Recruitment Status : Unknown
Verified January 2016 by Murali Janakiram, Albert Einstein College of Medicine, Inc..
Recruitment status was:  Active, not recruiting
First Posted : July 15, 2013
Last Update Posted : January 12, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Murali Janakiram, Albert Einstein College of Medicine, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : March 2015
  Study Completion Date : No date given